Treatment of Upper Limb Thrombosis
The appropriate treatment for upper limb thrombosis includes immediate anticoagulation with heparin followed by 3 months of anticoagulant therapy for unprovoked cases, with consideration for longer treatment only in specific risk scenarios. 1
Initial Management
Immediate Anticoagulation
- Start parenteral anticoagulation immediately upon diagnosis or high clinical suspicion
- Options include:
- Low-molecular-weight heparin (LMWH) - preferred option
- Unfractionated heparin (UFH) - intravenous or subcutaneous
- Fondaparinux 2
Diagnostic Evaluation
- Ultrasound Duplex Doppler is the first-line imaging test
- CT or MR venography may be necessary if ultrasound is inconclusive
- Evaluate for hypercoagulability with:
- Prothrombin time, partial thromboplastin time, platelet count
- Factor V Leiden, factor II (prothrombin) C-20210a
- Anti-cardiolipin antibody, protein C, protein S, anti-thrombin III 1
Treatment Duration and Approach
For Unprovoked Upper Limb DVT
- Treat for 3 months initially
- Long-term anticoagulant therapy is not routinely recommended in the absence of continuing risk factors 1
Special Considerations for Extended Anticoagulation
Extended anticoagulation should be considered in patients with:
- Indwelling central venous catheter
- Persistent thoracic outlet syndrome
- Severe post-thrombotic syndrome 1
Catheter Management
- Central venous catheters do not necessarily need to be removed if they remain functional
- This approach has been shown to be safe and efficacious in observational studies 1
Advanced Treatment Options
For Acute Limb Ischemia with Thrombosis
If the upper limb thrombosis is causing acute limb ischemia:
For native-vessel thrombosis with viable limb:
- Catheter-directed thrombolysis is recommended
- Options include alteplase, reteplase, or urokinase
- Consider glycoprotein IIb/IIIa antagonist (abciximab) to reduce distal emboli 1
Additional endovascular options:
- Ultrasound-assisted thrombolysis
- Suction embolectomy
- Rheolytic therapy 1
Surgical approaches:
- Reserve for cases where thrombolysis/endovascular approaches fail
- Consider when delay in treatment would jeopardize limb viability
- Options include catheter embolectomy and bypass 1
Post-Treatment Management
- Evaluate and treat underlying anatomical abnormalities (e.g., thoracic outlet syndrome)
- Consider imaging studies such as CT or MR venography to define sites of obstruction
- For thoracic outlet syndrome, vascular surgical intervention may be appropriate to avoid long-term anticoagulation 1
- Apply graduated compression stockings to prevent post-thrombotic syndrome 2
Important Caveats
- Recurrence rate for upper limb DVT appears to be low (<5%) in the first year after discontinuing anticoagulation, unlike lower limb DVT 1
- The risk-benefit assessment for thrombolysis must consider the extent and clinical impact of thrombosis versus bleeding risk 1
- Treatment decisions should prioritize mortality and limb salvage outcomes, with endovascular approaches showing lower mortality but potentially higher rates of recurrent ischemia compared to surgical approaches 1
Remember that while most upper limb thromboses are provoked by central venous catheters, thoracic outlet syndrome is another important risk factor that requires specific evaluation and may need surgical intervention 1.